v3.25.4
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]      
Revenues $ 0 $ 0 $ 0
Operating expenses:      
Research and development 344,955 101,644 63,806
General and administrative 48,387 49,277 37,021
Total operating expenses 393,342 150,921 100,827
Loss from operations (393,342) (150,921) (100,827)
Other income (expense):      
Amortization of financing costs (56) (94) (88)
Interest income, net 33,704 40,940 15,020
Realized gain on investments, net 55 112 0
Total other income, net 33,703 40,958 14,932
Net loss (359,639) (109,963) (85,895)
Other comprehensive loss, net of tax:      
Unrealized gain (loss) on securities 1,119 (173) 742
Foreign currency translation gain (loss) 47 (226) (29)
Comprehensive loss $ (358,473) $ (110,362) $ (85,182)
Basic net loss per common share $ (3.19) $ (1.01) $ (0.91)
Weighted-average shares used to compute basic net loss per share 112,667,303 109,037,122 94,346,991
Diluted net loss per common share $ (3.19) $ (1.01) $ (0.91)
Weighted-average shares used to compute diluted net loss per share 112,667,303 109,037,122 94,346,991